We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
The relationship of hepatitis B virus infection and non-Hodgkin’s lymphoma and its impact on clinical characteristics and prognosis.
- Authors
Soon-Thye Lim; Gao Fei; Quek, Richard; Lay-Cheng Lim; Lai-Heng Lee; Swee-Peng Yap; Loong, Susan; Tao, Miriam
- Abstract
Aim of the study: This study aims to evaluate the association between hepatitis B virus (HBV) and lymphoma and to characterize HBV-related lymphomas. The efficacy of prophylactic lamivudine on HBV reactivation was also evaluated. Methods: We compared the prevalence rate of HBV infection in 556 patients with lymphoma seen over a 4-yr period with that in a group of 4698 Singapore residents aged 18–69 who participated in the National Health Survey. Next, we compared the clinic-pathologic characteristics of HBV-positive and HBV-negative lymphoma cases. Results: The prevalence rate of HBV infection in our study was 10.3% (57/556), higher than the prevalence rate of 4.1% (192/4698) in the general population ( P ≤ 0.001). The higher prevalence was observed in both sexes and across different age groups. An association was observed for non-Hodgkin’s lymphoma (NHL) but not Hodgkin’s lymphoma. The characteristics of HBV-infected patients with lymphoma were similar to those who were HBV-uninfected in terms of age, ECOG, extra-nodal involvement, LDH level, stage, complete remission rate and overall survival. Use of prophylactic lamivudine significantly decreased the incidence of HBV reactivation (13% vs. 38%, P = 0.02) and disruption to chemotherapy (43% vs. 4%, P = 0.02), with a trend towards improved overall survival. Conclusions: Our findings suggest that an association exists between HBV infection and NHL. However, HBV infection does not appear to have a significant impact on the clinical characteristics and prognosis of NHL. Prophylactic lamivudine should be considered in all HBV-infected patients receiving antracycline and/or steroid containing chemotherapy.
- Subjects
HEPATITIS B virus; PROGNOSIS; LYMPHOMAS; DRUG therapy; HEALTH surveys
- Publication
European Journal of Haematology, 2007, Vol 79, Issue 2, p132
- ISSN
0902-4441
- Publication type
Article
- DOI
10.1111/j.1600-0609.2007.00878.x